Clearmind Medicine Inc (CMND)

$0.29 -0.06 (-17.62%)
Market Cap 1.89M
Revenue (ttm) 0.00
Net Income (ttm) -5.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 9,085,200
Avg Vol 8,455,892
Day's Range N/A - N/A
Shares Out 5.47M
Stochastic %K 8%
Beta 0.97
Analysts Strong Buy
Price Target N/A

Company Profile

Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well...

Industry: Biotechnology
Sector: Healthcare
Phone: 973 536 1016
Address:
1220 West 6th Avenue, Suite 101, Vancouver, Canada
Marketmovers456
Marketmovers456 Nov. 15 at 9:56 PM
$CYPH $GLTO $MOVE $BNAI $CMND
0 · Reply
KevMomentum
KevMomentum Nov. 15 at 9:26 PM
WEEKLY RECAP: 37 trades, 88.24% winrate +5.06% avg win, -3.28% avg loss Trade of the week: $CMND +21.15% +11.0R on the week How'd your week go?
0 · Reply
Frenchblaze420
Frenchblaze420 Nov. 15 at 5:30 PM
$CMND dont know what to think of this stock but will keep it under my radar willing to put 7k for as long as it dosent plummet back down to penny land honest opinion should invest monday or no
1 · Reply
Mandow1
Mandow1 Nov. 15 at 4:49 PM
$CMND I think this is a double bottom that’s forming and it’s going to go higher. FDA approval is a big deal. It’s best to get in early on this pull back.
0 · Reply
NathanThurm
NathanThurm Nov. 15 at 4:16 PM
$CMND So, like me, CMND is going wake up and take a dump on Monday. I'll be sure to hit the fan.
0 · Reply
retirementsoon2
retirementsoon2 Nov. 15 at 1:46 PM
$CMND https://www.youtube.com/watch?v=ddxrupawkXM
0 · Reply
Figsandates880
Figsandates880 Nov. 15 at 6:24 AM
$CMND what are we expecting guys im tryna make this my short squeeze for monday
0 · Reply
ItzOsorio
ItzOsorio Nov. 15 at 3:56 AM
$CMND This is going to be found over the weekend.
0 · Reply
G3HOPEWELL
G3HOPEWELL Nov. 15 at 2:30 AM
$CMND🐂
0 · Reply
FINTECFA
FINTECFA Nov. 15 at 12:50 AM
$CMND they be chasing this next week
0 · Reply
Latest News on CMND
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Nov 13, 2025, 8:54 AM EST - 2 days ago

Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment

Nov 12, 2025, 6:25 AM EST - 3 days ago

Clearmind Medicine Announces Notice of Patent Publication for Depression Treatment

Clearmind Medicine Successfully Completed First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Nov 10, 2025, 8:07 AM EST - 5 days ago

Clearmind Medicine Successfully Completed First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Nov 6, 2025, 4:02 PM EST - 9 days ago

Clearmind Medicine Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Nov 5, 2025, 6:55 AM EST - 10 days ago

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Oct 30, 2025, 7:55 AM EDT - 16 days ago

Clearmind Medicine Completes First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at Women in Psychedelic Leadership Webinar

Oct 28, 2025, 8:08 AM EDT - 18 days ago

Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at Women in Psychedelic Leadership Webinar

Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact to Advance US Partnerships and Governmental Engagement

Oct 27, 2025, 9:22 AM EDT - 19 days ago

Clearmind Medicine Appoints Mary-Elizabeth Gifford as Chief of Global Impact to Advance US Partnerships and Governmental Engagement

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Oct 21, 2025, 7:25 AM EDT - 25 days ago

Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Oct 20, 2025, 7:41 AM EDT - 26 days ago

Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders

Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

Sep 25, 2025, 7:40 AM EDT - 7 weeks ago

Clearmind Medicine's Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

Sep 19, 2025, 8:20 AM EDT - 2 months ago

Clearmind Medicine Secures $10 million Securities Purchase Agreement to Explore Strategic Opportunities

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Aug 7, 2025, 7:32 AM EDT - 3 months ago

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Aug 5, 2025, 8:15 AM EDT - 3 months ago

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Jul 30, 2025, 8:18 AM EDT - 3 months ago

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Jul 23, 2025, 8:55 AM EDT - 4 months ago

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Jul 15, 2025, 8:05 AM EDT - 4 months ago

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Jul 3, 2025, 8:47 AM EDT - 4 months ago

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

Jun 30, 2025, 9:16 AM EDT - 4 months ago

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

Jun 27, 2025, 9:00 AM EDT - 5 months ago

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Jun 25, 2025, 7:48 AM EDT - 5 months ago

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Jun 24, 2025, 8:06 AM EDT - 5 months ago

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Jun 23, 2025, 7:55 AM EDT - 5 months ago

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Jun 12, 2025, 9:25 AM EDT - 5 months ago

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

Jun 5, 2025, 7:32 AM EDT - 5 months ago

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

May 20, 2025, 9:00 AM EDT - 6 months ago

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Apr 25, 2025, 7:59 AM EDT - 7 months ago

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

SPRC

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Apr 25, 2025, 7:55 AM EDT - 7 months ago

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

Apr 23, 2025, 8:25 AM EDT - 7 months ago

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Apr 17, 2025, 7:38 AM EDT - 7 months ago

Clearmind Medicine Receives Notice of Allowance for United States Patent Covering Binge Behavior

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Apr 16, 2025, 8:40 AM EDT - 7 months ago

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Apr 10, 2025, 8:25 AM EDT - 7 months ago

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Apr 8, 2025, 6:55 AM EDT - 7 months ago

Clearmind Medicine Announces the Publication of International Patent Application for Next-Gen Psychedelic Compounds to Treat Mental Health Disorders

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Apr 1, 2025, 8:15 AM EDT - 8 months ago

Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Mar 21, 2025, 9:28 AM EDT - 8 months ago

Clearmind Medicine's FDA-Approved Clinical Trial for CMND-100 Moves Forward as Drug Arrives in the U.S., Advancing Toward Key Milestones

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Mar 19, 2025, 7:35 AM EDT - 8 months ago

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

Mar 18, 2025, 7:32 AM EDT - 8 months ago

Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Feb 4, 2025, 8:35 AM EST - 10 months ago

Clearmind Medicine Announces Publication of Patent for Binge Behavior Psychedelic Combination Treatment in Mexico

Clearmind Medicine Announces Shareholders Meeting Results

Jan 7, 2025, 9:28 AM EST - 11 months ago

Clearmind Medicine Announces Shareholders Meeting Results

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Jan 6, 2025, 8:15 AM EST - 11 months ago

Clearmind Medicine Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Jan 2, 2025, 7:45 AM EST - 11 months ago

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Dec 26, 2024, 6:59 AM EST - 11 months ago

Clearmind Medicine Looks to Move Forward with its Novel Psychedelic MEAI- Based Alcohol Substitute

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Dec 24, 2024, 6:55 AM EST - 11 months ago

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

Dec 16, 2024, 8:37 AM EST - 11 months ago

Clearmind Medicine and Dr Glitter Pty Ltd Sign Term Sheet for Mutual Development of Novel Psychedelic MEAI- Based Alcohol Substitute in ActivCrystal™ Format

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Oct 10, 2024, 8:07 AM EDT - 1 year ago

Clearmind Medicine Announces IRB Approval for FDA First-In-Human Clinical Trial of CMND-100 at Second Clinical Site

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Sep 16, 2024, 4:06 PM EDT - 1 year ago

Clearmind Medicine Announces the Notice of an International Patent Application for Pioneering Ibogaine Combination Therapy

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Sep 12, 2024, 8:20 AM EDT - 1 year ago

Clearmind Medicine and Yissum File International Patent Application for Revolutionary Psychedelic Compounds for PTSD Treatment

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Sep 6, 2024, 7:55 AM EDT - 1 year ago

Clearmind Medicine Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

Aug 29, 2024, 4:25 PM EDT - 1 year ago

Clearmind Medicine Announces Publication of its Patent Application for Innovative Ketamine-Based Combination Treatment

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

Aug 21, 2024, 4:11 PM EDT - 1 year ago

Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment

Marketmovers456
Marketmovers456 Nov. 15 at 9:56 PM
$CYPH $GLTO $MOVE $BNAI $CMND
0 · Reply
KevMomentum
KevMomentum Nov. 15 at 9:26 PM
WEEKLY RECAP: 37 trades, 88.24% winrate +5.06% avg win, -3.28% avg loss Trade of the week: $CMND +21.15% +11.0R on the week How'd your week go?
0 · Reply
Frenchblaze420
Frenchblaze420 Nov. 15 at 5:30 PM
$CMND dont know what to think of this stock but will keep it under my radar willing to put 7k for as long as it dosent plummet back down to penny land honest opinion should invest monday or no
1 · Reply
Mandow1
Mandow1 Nov. 15 at 4:49 PM
$CMND I think this is a double bottom that’s forming and it’s going to go higher. FDA approval is a big deal. It’s best to get in early on this pull back.
0 · Reply
NathanThurm
NathanThurm Nov. 15 at 4:16 PM
$CMND So, like me, CMND is going wake up and take a dump on Monday. I'll be sure to hit the fan.
0 · Reply
retirementsoon2
retirementsoon2 Nov. 15 at 1:46 PM
$CMND https://www.youtube.com/watch?v=ddxrupawkXM
0 · Reply
Figsandates880
Figsandates880 Nov. 15 at 6:24 AM
$CMND what are we expecting guys im tryna make this my short squeeze for monday
0 · Reply
ItzOsorio
ItzOsorio Nov. 15 at 3:56 AM
$CMND This is going to be found over the weekend.
0 · Reply
G3HOPEWELL
G3HOPEWELL Nov. 15 at 2:30 AM
$CMND🐂
0 · Reply
FINTECFA
FINTECFA Nov. 15 at 12:50 AM
$CMND they be chasing this next week
0 · Reply
everythingsok
everythingsok Nov. 14 at 11:14 PM
$CMND Took a few tenths off the average this evening. Wish you all a most excellent weekend.
0 · Reply
nightstocker15
nightstocker15 Nov. 14 at 10:38 PM
$CMND back on watch for Monday morning run again. Never know with this one, can take off out of nowhere like before. Get in before the crowd arrives again 👀
0 · Reply
Bazzzigar
Bazzzigar Nov. 14 at 10:14 PM
$CMND few more
0 · Reply
Mandow1
Mandow1 Nov. 14 at 10:06 PM
$CMND this will gap up Monday will catch a lot off guard
1 · Reply
newbulloh2
newbulloh2 Nov. 14 at 10:00 PM
$CMND looking for that ultra dip , still lots of sellers and no buyers haha
0 · Reply
dogood
dogood Nov. 14 at 9:28 PM
$CMND same here unnecessarily and unfortunately down after fda approvals
0 · Reply
FINTECFA
FINTECFA Nov. 14 at 9:27 PM
$CMND in again at 26.50. This should pump again next week. Have a great weekend.
1 · Reply
Snackdaddy
Snackdaddy Nov. 14 at 9:17 PM
$CMND watching .25 if doesnt hold will buy at .20 for a 2x play
0 · Reply
Eddie5150
Eddie5150 Nov. 14 at 9:15 PM
$CMND
0 · Reply
newbulloh2
newbulloh2 Nov. 14 at 8:56 PM
$CMND still 0 value in this one today okay will check back when new 52 week low hits sale sale sale
0 · Reply
retirementsoon2
retirementsoon2 Nov. 14 at 8:56 PM
$CMND time to buy for the next run
0 · Reply
scamfinder62
scamfinder62 Nov. 14 at 8:46 PM
$CMND trashhhhhhh
0 · Reply